drugset / Trial / NCT01711073

Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease

NCT01711073

NaSingle-groupOpen-labelTreatment

Summary

A phase I trial to study the safety of mobilization of stem cells with G-CSF and Mozobil in patients with chronic liver disease.

Timeline

Start
2012-10
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Plerixafor Small molecule
Subject filgrastim Protein / enzyme biologic

Indications